Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2018 - 2023)

Historic Long-Term Debt Issuances for X4 Pharmaceuticals (XFOR) over the last 4 years, with Q3 2023 value amounting to $22.5 million.

  • X4 Pharmaceuticals' Long-Term Debt Issuances changed N/A to $22.5 million in Q3 2023 from the same period last year, while for Dec 2024 it was $22.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $20.0 million for FY2024, which is 1111.11% down from last year.
  • Per X4 Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at $22.5 million for Q3 2023.
  • X4 Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $22.5 million during Q3 2023, with a 5-year trough of $4.9 million in Q1 2020.
  • In the last 3 years, X4 Pharmaceuticals' Long-Term Debt Issuances had a median value of $8.7 million in 2019 and averaged $11.2 million.